Showing 1 to 10 of 13 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.
Morpheus study (no surgery) NCT03051464  Recruiting
|
CISSS DE L'OUTAOUAIS
HOPITAL DE GATINEAU
|
Colon and Rectum |
Dr. Robert Archambault Céline Roy 819-966-6100 poste 3669 |
|
A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.
Morpheus study (no surgery) NCT03051464 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Colon and Rectum |
Dr. Carole Richard Nassima Taleb 514-890-8000 poste 10812 |
|
A Proof-of-Concept Phase II Trial to Evaluate the EMT Inhibitor Sotevtamab Combined With FOLFOX Administered as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
EGIA-003 NCT06225843 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Colon and Rectum |
Dr. Mustapha Tehfé Chantal Gosselin 514-890-8000 poste 24892 |
|
An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
MOUNTAINEER-03 NCT05253651 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Colon and Rectum |
Dr. Petr Kavan Oleg Lapsin 514-340-8222 poste 28437 |
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Colon and Rectum |
Dr. Frédéric Lemay Michelle Roy 819-346-1110 poste 12848 |
|
Phase II Study to Assess the Safety of Non-operative Management for Low Rectal Cancer
PJT - 148730 (NOM - rectal cancer) NCT03179540 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL SAINT-FRANCOIS D'ASSISE
|
Colon and Rectum |
Dr. Sébastien Drolet Nicole Chabot 418-525-4444 poste 53266 |
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Colon and Rectum |
Dr. Maxime Chénard-Poirier Alice Ndayizigiye 418-525-4444 poste 15782 |
|
A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.
Morpheus study (no surgery) NCT03051464 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Colon and Rectum |
Dr. Té Vuong Emma Starr 514-340-8222 poste 28443 |
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Colon and Rectum |
Dr. Petr Kavan Aline Mamo 514-340-8222 poste 5525 |
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) (CIRCULATE-US) NCT05174169 Recruiting
|
CIUSSS DU NORD-DE-L'ILE-DE-MONTREAL
HOPITAL DU SACRE-COEUR-DE-MONTREAL
|
Colon and Rectum |
Dr. Setareh Samimi Maia Labelle 514-338-2222 poste 2818 |
Groupe d'étude en oncologie du Québec